Found: 6
Select item for more details and to access through your institution.
Integrated multiomic approach for identification of novel immunotherapeutic targets in AML.
- Published in:
- Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00390-4
- By:
- Publication type:
- Article
Integrated multiomic approach for identification of novel immunotherapeutic targets in AML.
- Published in:
- Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00390-4
- By:
- Publication type:
- Article
RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1505, doi. 10.1007/s00262-015-1755-8
- By:
- Publication type:
- Article
Recent developments in immunotherapy of acute myeloid leukemia.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0505-0
- By:
- Publication type:
- Article
Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
An Advanced Preclinical Mouse Model for Acute Myeloid Leukemia Using Patients' Cells of Various Genetic Subgroups and In Vivo Bioluminescence Imaging.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0120925
- By:
- Publication type:
- Article